| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 4 | 4 | 4 | 100% | +0.2% | +0.2% |
| 3d | 4 | 4 | 4 | 100% | +0.2% | +0.2% |
| 1w | 4 | 4 | 4 | 100% | +2.8% | +2.8% |
| 1m | 4 | 4 | 4 | 100% | +3.0% | +3.0% |
| 3m | 4 | 4 | 4 | 100% | +9.2% | +9.2% |
| 6m | 0 | 0 | 0 | — | — | — |
| 1y | 0 | 0 | 0 | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
NVDA is undervalued given 80% revenue growth YoY. Author is levered long via 3x 320/420c call spreads (Sep 2027 expiry), betting on longer-dated upside.
NVDA is undervalued given 80% revenue growth YoY. Author is levered long via 20x 210/215c call spreads (Nov expiry), betting on near-term upside.
NVDA is undervalued given 80% revenue growth YoY. Author is levered long via 1x 230c 1/21/28 call, betting on sustained upside with a Jan 2028 expiry.
NVDA is undervalued given 80% revenue growth YoY. Author is levered long via 59 shares, multiple call spreads (210/215c Nov, 320/420c Sep '27), and a 230c Jan 2028 call, betting on continued upside.
End of results.